The Limited Storage Capacity of Gonadal Adipose Tissue Directs the Development of Metabolic Disorders in Male C57Bl/6J Mice

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2015 May 13

PMID 25962520

Citations 36

Authors

Lianne van Beek

Jan B van Klinken

Amanda C M Pronk

Andrea D van Dam

Eline Dirven

Patrick C N Rensen

Frits Koning

Ko Willems van Dijk

Vanessa van Harmelen

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: White adipose tissue (WAT) consists of various depots with different adipocyte functionality and immune cell composition. Knowledge of WAT-depot-specific differences in expandability and immune cell influx during the development of obesity is limited, therefore we aimed to characterise different WAT depots during the development of obesity in mice.

Methods: Gonadal WAT (gWAT), subcutaneous WAT (sWAT) and mesenteric WAT (mWAT) were isolated from male C57Bl/6J mice with different body weights (approximately 25-60 g) and analysed. Linear and non-linear regression models were used to describe the extent of WAT depot expandability and immune cell composition as a function of body weight.

Results: Whereas mouse sWAT and mWAT continued to expand with body weight, gWAT expanded mainly during the initial phase of body weight gain. The expansion diminished after the mice reached a body weight of around 40 g. From this point on, gWAT crown-like structure formation, liver steatosis and insulin resistance occurred. Mouse WAT depots showed major differences in immune cell composition: gWAT consisted mainly of macrophages, whereas sWAT and mWAT primarily contained lymphocytes.

Conclusions/interpretation: Marked inter-depot differences exist in WAT immune cell composition and expandability. The limited storage capacity of gWAT seems to direct the development of metabolic disorders in male C57Bl/6J mice.

Citing Articles

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature.

Igual-Gil C, Bishop C, Jahnert M, Johann K, Coleman V, Baum V Sci Rep. 2024; 14(1):26989.

PMID: 39505926 PMC: 11541726. DOI: 10.1038/s41598-024-77448-w.

History and future perspectives of adipose tissue macrophage biology.

Kado T, Nishimura A, Tobe K Front Pharmacol. 2024; 15:1373182.

PMID: 38562458 PMC: 10982364. DOI: 10.3389/fphar.2024.1373182.

Atherosclerosis: an overview of mouse models and a detailed methodology to quantify lesions in the aortic root.

van der Vaart J, van Eenige R, Rensen P, Kooijman S Vasc Biol. 2024; 6(1).

PMID: 38428154 PMC: 11046329. DOI: 10.1530/VB-23-0017.

Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer.

Xu G, Zhao Z, Wysham W, Roque D, Fang Z, Sun W Front Oncol. 2023; 13:1219923.

PMID: 37601677 PMC: 10436609. DOI: 10.3389/fonc.2023.1219923.

Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome.

Patrick K, Tian X, Cartwright D, Heising S, Glover M, Northall E PLoS One. 2023; 18(4):e0284012.

PMID: 37115796 PMC: 10146461. DOI: 10.1371/journal.pone.0284012.

References

Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M . CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009; 15(8):914-20. DOI: 10.1038/nm.1964. View

Wang Q, Tao C, Gupta R, Scherer P . Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med. 2013; 19(10):1338-44. PMC: 4075943. DOI: 10.1038/nm.3324. View

Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005; 46(11):2347-55. DOI: 10.1194/jlr.M500294-JLR200. View

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

van Beek L, Lips M, Visser A, Pijl H, Ioan-Facsinay A, Toes R . Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism. 2014; 63(4):492-501. DOI: 10.1016/j.metabol.2013.12.002. View

Bjorndal B, Burri L, Staalesen V, Skorve J, Berge R . Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes. 2011; 2011:490650. PMC: 3042633. DOI: 10.1155/2011/490650. View

Tran T, Yamamoto Y, Gesta S, Kahn C . Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008; 7(5):410-20. PMC: 3204870. DOI: 10.1016/j.cmet.2008.04.004. View

Vatier C, Kadiri S, Muscat A, Chapron C, Capeau J, Antoine B . Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis. Nutr Diabetes. 2012; 2:e51. PMC: 3542433. DOI: 10.1038/nutd.2012.29. View

Strissel K, Stancheva Z, Miyoshi H, Perfield 2nd J, Defuria J, Jick Z . Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007; 56(12):2910-8. DOI: 10.2337/db07-0767. View

10.

Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M . T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008; 28(7):1304-10. DOI: 10.1161/ATVBAHA.108.165100. View

11.

Despres J, Lemieux I . Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7. DOI: 10.1038/nature05488. View

12.

Joe A, Yi L, Even Y, Vogl A, Rossi F . Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells. 2009; 27(10):2563-70. DOI: 10.1002/stem.190. View

13.

Skurk T, Alberti-Huber C, Herder C, Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2006; 92(3):1023-33. DOI: 10.1210/jc.2006-1055. View

14.

Prieur X, Mok C, Velagapudi V, Nunez V, Fuentes L, Montaner D . Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 2011; 60(3):797-809. PMC: 3046840. DOI: 10.2337/db10-0705. View

15.

Bigornia S, Farb M, Mott M, Hess D, Carmine B, Fiscale A . Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes. 2013; 2:e30. PMC: 3341707. DOI: 10.1038/nutd.2012.3. View

16.

Wu H, Ghosh S, Perrard X, Feng L, Garcia G, Perrard J . T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007; 115(8):1029-38. DOI: 10.1161/CIRCULATIONAHA.106.638379. View

17.

Chau Y, Bandiera R, Serrels A, Martinez-Estrada O, Qing W, Lee M . Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014; 16(4):367-75. PMC: 4060514. DOI: 10.1038/ncb2922. View

18.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

19.

Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112(12):1821-30. PMC: 296998. DOI: 10.1172/JCI19451. View

20.

Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M . Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res. 2008; 49(7):1562-8. DOI: 10.1194/jlr.M800019-JLR200. View